XML 89 R78.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivatives - Schedule of the Activity for Derivatives Instruments Designated as Cash Flow Hedges (Detail) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) $ 20,719 $ 22,262
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion) 205 (28)
Gain/(Loss) from Amounts Excluded from Effectiveness Testing   2
Gain/(Loss) Recognized in AOCI (Effective Portion) (1,328) 7,755
Cost of Sales [Member]    
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) (15,978) (17,293)
Selling, General and Administrative Expense [Member]    
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) (10)  
Foreign Exchange Gains, Net [Member]    
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) (491)  
Interest Expense, Net [Member]    
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) 4 (4)
Interest Rate Lock [Member] | Interest Expense, Net [Member]    
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) (5) 5
Foreign Exchange Contracts [Member]    
Derivative [Line Items]    
Gain/(Loss) Recognized in AOCI (Effective Portion) (1,669) 9,981
Foreign Exchange Contracts [Member] | Cost of Sales [Member]    
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) 20,093 22,257
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion) 205 (28)
Foreign Exchange Contracts [Member] | Selling, General and Administrative Expense [Member]    
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) 13  
Foreign Exchange Contracts [Member] | Foreign Exchange Gains, Net [Member]    
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) $ 618  
Gain/(Loss) from Amounts Excluded from Effectiveness Testing   $ 2